QTL associated with activity-distance traveled 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (21685340)
QTL associated with cocaine induced activation 6. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (37920888)
QTL associated with estradiol regulated response QTL 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (32779113)
Authors:
Roper RJ, Griffith JS, Lyttle CR, Doerge RW, McNabb AW, Broadbent RE, Teuscher C
QTL associated with induction of brown adipocytes 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (37920888)
QTL associated with insulin dependent diabetes susceptibility 15. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (8797672)
Authors:
McAleer MA, Reifsnyder P, Palmer SM, Prochazka M, Love JM, Copeman JB, Powell EE, Rodrigues NR, Prins JB, Serreze DV
QTL associated with immune response to Factor IX QTL 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (24424937)
Authors:
Zhang HG, High KA, Wu Q, Yang P, Schlachterman A, Yu S, Yi N, Hsu HC, Mountz JD
QTL associated with postnatal body weight growth 14. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (4223455)
QTL associated with skin tumor susceptibility 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (38901191)
QTL associated with ventral midbrain iron content 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (44449245)
Authors:
Jones BC, Reed CL, Hitzemann R, Wiesinger JA, McCarthy KA, Buwen JP, Beard JL
QTL associated with vertebral morphology and mechanical traits 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (27281935)
Authors:
Reeves GM, McCreadie BR, Chen S, Galecki AT, Burke DT, Miller RA, Goldstein SA
Here, female High Drinking in the Dark (HDID) mice were stereotaxically injected with 0.5uL rAAV2/5-CMV-Cre-GFP and 0.5uL rAAV2-hSyn-DIO-hM3Dq-mCherry bilaterally into the NAc. A Drinking in the Dark (DID) experiment lasting 6 weeks was carried out with 2 fluid groups (water or ethanol) and 2 treatment groups (VEH/VEH/VEH or VEH/CNO/VEH). Mice were serially treated with vehicle prior to DID during week 1 to establish baseline drinking, CNO (1mg/kg) during weeks 2-5 to measure the effects of chronic treatment, and then mice were treated with vehicle again during week 6 to determine if there were any lasting effects of chronic CNO treatment. This gene set comprises 1,473 genes that were differentially expressed in the nucleus accumbens of ethanol drinking HDID mice treated with vehicle as compared to the water drinking and vehicle treated control group.
Authors:
Darya Y. Pozhidayeva, Sean P. Farris, Calla M. Goeke, Evan J. Firsick, Kayla G. Townsley, Marina Guizzetti, and Angela R. Ozburn
Here, female High Drinking in the Dark (HDID) mice were stereotaxically injected with 0.5uL rAAV2/5-CMV-Cre-GFP and 0.5uL rAAV2-hSyn-DIO-hM3Dq-mCherry bilaterally into the NAc. A Drinking in the Dark (DID) experiment lasting 6 weeks was carried out with 2 fluid groups (water or ethanol) and 2 treatment groups (VEH/VEH/VEH or VEH/CNO/VEH). Mice were serially treated with vehicle prior to DID during week 1 to establish baseline drinking, CNO (1mg/kg) during weeks 2-5 to measure the effects of chronic treatment, and then mice were treated with vehicle again during week 6 to determine if there were any lasting effects of chronic CNO treatment. This gene set comprises 2,377 genes that were differentially expressed in the nucleus accumbens of ethanol drinking HDID mice treated with CNO as compared to the water drinking and vehicle treated control group.
Authors:
Darya Y. Pozhidayeva, Sean P. Farris, Calla M. Goeke, Evan J. Firsick, Kayla G. Townsley, Marina Guizzetti, and Angela R. Ozburn
RNA-seq of adult ventral stratum of naive selected lines (SOT and NOT). ~1800 genes differentially expressed p adjusted <0.05 between SOT and NOT.
Authors:
Laura B Kozell, Denesa Lockwood, Priscila Darakjian, Stephanie Edmunds, Karen Shepherdson, Kari J Buck, Robert Hitzemann
Add Selected GeneSets to Project(s)
Warning: You are not signed in. Adding these genesets to a project will create a guest account for you.
Guest accounts are temporary, and will be removed within 24 hours of creation. Guest accounts can be registered as full accounts, but you cannot associate a guest account with an existing account.
If you already have an account, you should sign into that account before proceeding.